WHO recommends Merck COVID pill for non-severe, at-risk patients

WHO recommends antiviral drug for patients with non-severe COVID-19 at highest risk of hospital admission
2 March 2022
An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis
3 March 2022

WHO recommends Merck COVID pill for non-severe, at-risk patients

The World Health Organization on Wednesday recommended an anti-COVID pill be taken by sufferers who have mild symptoms but are at high risk of hospitalization, such as older people or the unvaccinated.

Comments are closed.